Novo Nordisk Partners With Anthropic on Drug Research
Novo Nordisk is partnering with Anthropic to use Claude models in drug discovery and development, according to Reuters. The drugmaker will initially test the models and Claude Science in research and development workflows.
Claude Science is Anthropic's workbench for computational research, which connects its models with scientific tools and databases. Novo Nordisk and Anthropic will identify scientific problems where the technology can support research into human biology and drug mechanisms.
Novo Nordisk will also use Anthropic's models for software development. The company already uses Claude to automate trial report generation, reducing the time needed to create patient documentation from months to minutes.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 18 AMD to invest in PsiQuantum as the two co-design hybrid quantum computing infrastructure Nov 18 SK Group rolls out Harvey's legal AI across more than 20 affiliates Nov 18 Nvidia's startup stakes reach $65.5 billion as Kress signals more careful investing Nov 18 Amazon and Google will own nearly 30% of Anthropic after its IPO Nov 18 Workday creates Ireland-based company to run its EU Sovereign CloudMore from Life Sciences
Nov 18 nference and Novo Nordisk partner on AI research into obesity, diabetes and heart disease Nov 17 AI echo analysis lifts detection of a hard-to-diagnose heart failure type to 78% Nov 17 Astromech acquires Form Bio in $230 million all-stock deal Nov 17 The Rx Assistant launches Builder, a no-code platform for pharma AI experiences Nov 17 Isomorphic Labs raises $5 billion Series C for AI drug designEnterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
nference and Novo Nordisk partner on AI research into obesity, diabetes and heart disease
Anthropic Expands Free Claude Credits to 20 Science Groups
Anthropic Finds Researchers Use Claude Mostly for Data Analysis
Anthropic launches Claude Meetings to join video calls and work on tasks live, plus Whiteboards and Sheets
Cognizant puts more than 25,000 staff on Claude and launches managed services to run it
Daily AI Brief: the AI news that matters, in your inbox.